These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6613833)

  • 1. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
    Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
    Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
    Simonian SM; Lotfipour S; Wall C; Langdorf MI
    Intern Emerg Med; 2010 Oct; 5(5):421-6. PubMed ID: 20437113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
    Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
    Tuzcu EM; Gilbo J; Masterson M; Maloney JD
    Cleve Clin J Med; 1989 May; 56(3):238-42. PubMed ID: 2743545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
    Wellens HJ; Brugada P; Abdollah H; Dassen WR
    Circulation; 1984 Jan; 69(1):120-4. PubMed ID: 6689635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
    Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ
    Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
    Feld GK; Nademanee K; Weiss J; Stevenson W; Singh BN
    J Am Coll Cardiol; 1984 May; 3(5):1298-307. PubMed ID: 6707383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.